Epidemiology, Clinical Presentation and Treatment of Non-Hepatic Hyperammonemia in ICU COVID-19 Patients

(1) Background: Although COVID-19 is largely a respiratory disease, it is actually a systemic disease that has a wide range of effects that are not yet fully known. The aim of this study was to determine the incidence, predictors and outcome of non-hepatic hyperammonemia (NHH) in COVID-19 in intensi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Nardi Tetaj, Giulia Valeria Stazi, Maria Cristina Marini, Gabriele Garotto, Donatella Busso, Silvana Scarcia, Ilaria Caravella, Manuela Macchione, Giada De Angelis, Rachele Di Lorenzo, Alessandro Carucci, Alessandro Capone, Andrea Antinori, Fabrizio Palmieri, Gianpiero D’Offizi, Fabrizio Taglietti, Stefania Ianniello, Paolo Campioni, Francesco Vaia, Emanuele Nicastri, Enrico Girardi, Luisa Marchioni, on behalf of ICU COVID-19 Study Group
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2022-05-01
סדרה:Journal of Clinical Medicine
נושאים:
COVID-19
Coronavirus disease
intensive care unit
non-hepatic hyperammonemia
גישה מקוונת:https://www.mdpi.com/2077-0383/11/9/2592
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים